Effect of Maternal Hemoglobin on Neurobehavioural Development of Late Preterm Neonates : A Cohort Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-06-30

Study Completion Date

2014-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study entitled 'Effect of maternal hemoglobin on neurobehavioral development of late preterm neonates' was done with an objective to determine whether low maternal hemoglobin (\<11gm/dl), in late preterm neonates(\>34weeks but less than 37weeks gestational age) correlates with poor neurobehavioral outcome using the Neurobehavioral Assessment of Preterm Infants(NAPI) tool, thereby allowing for earlier rehabilitative intervention to be undertaken to improve their long term outcomes and to generate useful data on a previously well recognised but under researched entity.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Developmentally Supportive Care on Neurobehavioral Outcome of Preterm Very Low Birth Weight Neonates

NCT02817022

Very Low Birth Weight Baby

UNKNOWN NA

Linear Growth and Neurobehavioural Outcome in PT Neonates (<34 Wks) at 37 and 40 Wks of CGA

NCT02970994

PreTerm Birth

COMPLETED

Brief Delay in Cord Clamping and Neurobehaviour in Preterms

NCT01753843

Preterm Birth

COMPLETED NA

Effect of Infant Placement on Iron Stores in Infancy: A Pilot Study

NCT00675337

Iron Deficiency Anemia

UNKNOWN NA

Anemia of Prematurity and Hemodynamics

NCT05496400

Premature

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Prevalence of anemia in India is among the highest in the world. A high proportion of women in both industrialized and developing countries become anemic during pregnancy. The major concern about the adverse effects of anemia on pregnant women and their offsprings is the belief that this population is at a greater risk of perinatal mortality and morbidity. Apart from this, it is well known that anemia per se is associated with higher incidence of premature births and low birth weight babies. Infants with iron deficiency anemia have significantly lower motor and mental scores and decreased language capabilities and body balance-coordination skills. Such infants also have a decreased learning ability. Iron deficiency anemia during the developmental stage can lead to reduced myelination of the spinal cord, as well as a change in myelin composition; abnormalities in neurotransmitters' metabolism and alteration in brain energy metabolism. The Neurobehavioral Assessments of Preterm Infants (NAPI) is a research tool to monitor the developmental progress and differential maturity of preterm infants ranging between 32weeks and 37weeks (full term). This test is used to identify persistent lags in development, as a research tool to assess effects of interventions and to study individual differences and basic developmental questions. The reliability and clinical validity of this test has been thoroughly investigated and normative data has been established.

Objective - To evaluate the neurobehavioral development at 37weeks of post conceptional age in late preterm infants born to mothers with hemoglobin \<11gm/dl; by a standardised scale - Neurobehavioral Assessment of Preterm Infants (NAPI).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cases

Late preterm neonates (\>34weeks but \<37weeks of gestation) with maternal hemoglobin \< 11gm/dl

No interventions assigned to this group

Controls

Late preterm neonates (\>34weeks but \<37weeks of gestation) with maternal haemoglobin ≥ 11gm/dl

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Late preterm infants born to mothers \<35yrs of age and born between 34weeks to 36.6weeks of gestation as calculated by last menstrual period/1st trimester ultrasound
* Clinically stable from respiratory, hemodynamic and metabolic point of view
* After receiving full, free, voluntary, informed consent from parents/family members within 24 hours of delivery.

Exclusion Criteria

* Chorioamnionitis in pregnancy.
* Congenital malformations (antenatally diagnosed or evident on clinical examination)
* Neonates admitted to NICU
* Neonates requiring ventilator support
* Neonates with any neurological impairment (IVH etc)
* Neonates undergoing surgery
* Neonates with birth asphyxia
* Neonates with birth trauma
* Confirmed history of substance abuse in mother.

Minimum Eligible Age

34 Weeks

Maximum Eligible Age

37 Weeks

Eligible Sex

ALL

Accepts Healthy Volunteers

No